INTRODUCTION
Prolylcarboxypeptidase (peptidyl prolyl-amino acid hydrolase, EC 3.4.12.4) cleaves the C-terminal ProPhe bond in angiotensin II and des-Aspl-angiotensin II (angiotensin III) and also the Pro-Ala bond in the angiotensin II antagonist, Sarl-Ala8-angiotensin II 210 (saralasin) (1) (2) (3) (4) . The enzyme was first named angiotensinase C because it inactivates angiotensin II (1) .
Prolylcarboxypeptidase (PCP)' cleaves C-terminal amino acids of short synthetic peptides if they have a free carboxyl group and if they are linked to a penultimate proline. The amino group ofproline has to be protected or linked to another amino acid (2, 3) . PCP has an acidic pH optimum, but depending upon the structure of the substrate, 20-90% of the activity is retained at neutral pH (4) . PCP is found in human urine and in a lysosomal fraction of homogenized kidney and leukocytes (1) (2) (3) (4) (5) . The enzyme was purified from hog (6) and human kidneys (4) , and was also found in lung and cultured cells (7) . We used a recently synthesized, radiolabeled substrate to measure PCP activity in cultured cells, blood cells, and tissues. Fibroblasts cultured from human tissues have the highest PCP activity. These cells were used to study the properties of PCP and factors that affect its activity.
Ohio) and Isolymph was from Gallard-Schlesinger Chemical Mfg. Corp., Carle Place, N. Y.
Tissues. Human lungs were obtained at autopsy within 5 h of death. Rat lungs were perfused in situ with isotonic saline until the effluent was free of blood.
Lung tissue was taken from peripheral areas of several lobes and diced with scissors in 10 mM Tris/HCl (pH 7.4) containing 0.35 M sucrose (15% wt/vol) and homogenized with a Polytron homogenizer (Brinkmann Instruments, Inc., Westbury, N. Y.) for 20 s. Nuclei and cell debris were removed by centrifugation at 500 g for 10 min. The homogenate was then filtered through gauze and centrifuged at 10,000 g for 20 min in a Sorvall RC-5 centrifuge (DuPont Co. Instrument Products Div., Sorvall Biomedical Div., Wilmington, Del.). The pellet was suspended in a volume in milliliters of0.35 M sucrose equal to the weight in grams of tissue. The supernatant fluid was centrifuged at 105,000 g for 60 min in a Beckman L-5-65 ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) and the pellet was resuspended in the same volume as above. All samples were stored at -70°C and sonicated for 60 s immediately before assay.
Cell cultures. Fibroblasts from human foreskin, embryonic lung, umbilical cord skin, and synovium were cultured in medium 199 (Microbiological Associates, Inc., Bethesda, Md.) supplemented with 10% fetal calf serum, and antibiotics. Cells from foreskin, umbilical cord, and synovium were grown from tissue explants (8) . The lung fibroblasts, IMR 90, were obtained from the Institute ofMedical Research, Camden, N. J. Endothelial cells were isolated from human pulmonary arteries with collagenase (9) and grown in medium 199 supplemented with 10% human serum, 20% fetal calf serum, and antibiotics. All cultures were maintained at 37°C in an atmosphere of 5% CO2 and 95% air.
Confluent monolayers of cultured cells were used throughout except in experiments with hydrocortisone and polypeptide growth factors. For enzyme assays each flask of cells was rinsed twice with phosphate-buffered saline (pH 7.4), and the cells were detached with 0.125% trypsin in 10 mM Hepesbuffered saline with 1% glucose (pH 7.4). The cells were centrifuged to a pellet (400 g for 10 min) at room temperature and washed twice with Hepes-buffered saline. After the second wash, the cell pellet was resuspended in 1-3 ml of the same solution.
Blood cells. Polymorphonuclear neutrophils were isolated from peripheral venous blood of healthy individuals by centrifugation (10) on a sodium diatrizoate/Ficoll cushion (Isolymph). Residual erythrocytes were removed from the neutrophil pellet by hypotonic lysis in several samples, but the activity of PCP was unaffected by the presence of erythrocytes.
A similar method was used to prepare mononuclear leukocytes (11 Fibroblasts were plated on glass cover slips for the detection ofPCP by fluorescence microscopy. The cover slips were rinsed twice with phosphate-buffered saline (pH 7.4) containing 0.15 M NaCl and 2 mM MgCl2 and fixed with 3% formaldehyde. One of each pair was treated with 0.05% Triton X-100 in phosphate-buffered saline for 5 min at 100C. This step permits penetration ofthe antibody into the cells. The cover slips were rinsed twice with buffer, rabbit antiserum to human renal PCP was added, and they were incubated for 1 h at 370C. Controls were treated with normal (nonimmune) rabbit serum. All cover slips were washed twice, and fluorescein-isothiocyanate-labeled boat anti-rabbit gamma globulin was added. After a second incubation at 370C for 60 min, the cover slips were washed, mounted on glass slides, and inspected with a Leitz fluorescence microscope (E. Leitz, Inc., Rockleigh, N. J.).
Cell growth factors. The effect of hydrocortisone and epidermal or fibroblast growth factors on PCP was investigated with subconfluent monolayers of IMR-90 fibroblasts. Actively growing cells (30-50% confluent) were treated with epidermal or fibroblast growth factor (10 ng/ml) or hydrocortisone (0.1 mM-1 ,uM) for 96 h at 370C. The cultures remained undisturbed during this time and the medium was not changed. Triplicate dishes were prepared for each treatment or for controls that were treated only with standard culture medium. On the day of the assay, cells were detached with 0.125% trypsin and sonicated for 60 s at 40C. The lysed cells were centrifuged at 3,000 g for 10 min and the supernatant fluid was assayed for PCP activity.
PCP assay. The activity of PCP was determined by measuring the hydrolysis of Cbz-Pro-Ala at pH 5.0. The reaction mixture consisted of0.1 ml substrate, 0.02-0.1 ml enzyme, and 0.2 M sodium acetate buffer ( (Table I) and 46% of the total activity in human lungs sedimented in the lysosomal fraction. The same fraction in rat contained 48% of the lysosomal marker enzyme, ,(-glucuronidase. The final supernatant fluid and precipitate (microsomal fraction) had only 3-5% of the total PCP activity in rat lung and 5-16% in human lung. Characteristics of PCP in fibroblasts. The properties of PCP extracted from cultured human foreskin fibroblasts were similar to those of the purified human kidney enzyme (4). The fibroblast enzyme, just as renal PCP, was resistant to moderate heating (60°C) and was inhibited by p-phenylmethyl-sulfonylfluoride, but not by the SH enzyme inhibitor, p-chloromercuriphenyl sulfonic acid (Table III) . Chloroquine inhibited PCP in a dose-related manner; 30% of the activity was inhibited at 0.1 mM and 70% was inhibited at 1 mM concentration ofthe inhibitor. Adding the substrate cathepsin A (Cbz-Glu-Tyr) to the reaction mixture did not inhibit the hydrolysis of Cbz-Pro-Ala by PCP. Since Cbz-Glu-Tyr is not a competitive substrate, cathepsin A and PCP activities are due to different enzymes. However, fibroblasts have cathepsin A activity because the cells cleaved Cbz-Glu-Tyr at a rate of 1.17+0.4 ,umol/h per 106 cells. Like cathepsin A in other tissues (4), the fibroblast enzyme was inhibited 70% by 1 mM p-chloromercuriphenyl sulfonic acid, and 95% of the activity was lost when the cells were heated to 60°C for 30 min.
Immunofluorescence. PCP in fibroblasts has antigenic determinants in common with kidney PCP be-
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K. Kumamoto, T. A. Stewart, A. R. Johnson, and E. G. Erdos cause rabbit antiserum to purified human renal PCP reacted with the fibroblast enzyme (Fig. 1) . The fluorescence from anti-PCP developed with fluorescein isothiocyanate-labeled anti-rabbit gamma globulin was distributed throughout the cells. Preimmunized rabbit serum produced only a faint background fluorescence.
In cells not treated with Triton X-100 before application of the antibody to PCP there was little fluorescence, indicating that most of the enzyme is inside the cells. Growth factors and hydrocortisone. Neither epidermal nor fibroblast growth factor affected the PCP activity in actively growing fibroblasts, although they increased the cell number by 30-40%. The activity of PCP in growth factor-treated cells ranged from 97-115% of the control (untreated) cell activity.
When the fibroblasts were cultured in medium with hydrocortisone at a concentration of2 ,uM, PCP activity per cell decreased. Activity increased with higher concentrations of the drug (Fig. 2) . The changes in PCP activity by hydrocortisone were accompanied by parallel changes in ,8-glucuronidase activity (r = 0.965, n = 12, P < 0.001). These data are shown in Fig. 3 . Hydrocortisone treatment of the fibroblasts caused similar changes in protein concentration in the cells (r = 0.961, n = 12, P < 0.001) but the data are not shown.
PCP in synovial fluid. The substrates of PCP are proline peptides, and both leukocytes and fibroblasts have PCP activity. This enzyme could appear at sites of inflammation in connective tissues, such as in joints of patients with rheumatoid arthritis. The PCP activity in synovial fluids from five rheumatoid knee joints was 0.38±0.04 umol/h per ml. Maximum activity was obtained when 5-,l aliquots of synovial fluid were used as a source ofenzyme in the reaction mixtures. Activity decreased when larger volumes of fluid were used The immunofluorescence reaction was produced by treating cells with rabbit antibody to human renal PCP and then with fluorescein isothiocyanate-labeled goat anti-rabbit gamma globulin. without dilution, indicating the presence ofa reversible inhibitor.
DISCUSSION PCP was first identified in kidney, urine, and leukocytes (1-5); low PCP activity was also detected in rat liver and bovine spleen (14, 15) . Research on this enzyme has been hampered by the lack ofa simple, sensitive assay. When studies with substrates ofhuman renal PCP indicated that Cbz-Pro-Ala was cleaved four times faster than Cbz-Pro-Phe (4), radiolabeled Cbz-Pro-Ala was synthesized. This provided the basis for a sensitive assay that we applied to study PCP in human cells and tissues.
We found appreciable amounts ofthe enzyme in lysosomal fractions from human or rat lungs. The enzyme is also present in human cells isolated from peripheral venous blood, in cultured fibroblasts, and pulmonary endothelial cells.
PCP activity was initially detected in polymorphonuclear neutrophils (2, 4, 5) , but both lymphocytes and macrophages have higher activity than neutrophils. The presence of PCP in neutrophils, coupled with the fact that the enzyme has an acidic pH optimum (1, 2, 4) , suggests that the enzyme may have a role in inflammation. Since PCP cleaves peptide bonds only when the penultimate amino acid is proline (1-4) , it may cleave peptides from connective tissues.
PCP in the lung may be involved in angiotensin metabolism. Usually angiotensin II is not inactivated within the pulmonary circulation, but Bakhle and Vane (16) found that when isolated perfused lungs developed edema, angiotensin II was inactivated before it left the pulmonary circulation. Thus the peptide must be hydrolyzed either by enzymes released from damaged endothelial cells (17) or by enzymes within the tissues.
Angiotensin III (des-Aspl-angiotensin II) is cleaved by PCP more readily than angiotensin II (4) , and the presence of PCP in pulmonary vessels may prevent angiotensin III from entering the systemic circulation. Indeed, Gaynes et al. (18) found that very little labeled angiotensin III escapes passage through the pulmonary vascular bed.
Fibroblasts cultured from several tissues had two to three times more PCP activity than pulmonary arterial endothelial cells. Thus, the PCP activity in lung is mainly due to PCP presence in parenchymal tissues. The properties of fibroblast PCP are similar to those of PCP purified from human kidney (4) with respect to pH optimum, substrate specificity, and sensitivity to heating and chemical inhibitors. In addition, there are common antigenic determinants between the fibroblast and renal enzymes, as indicated by our immunofluorescence experiments.
Cathepsin A is another enzyme with an acidic pH optimum that can cleve Phe8 ofangiotensin II (19) , but it differs from PCP in many respects (1, 2, 4, (20) (21) (22) (23) . Cultured human fibroblasts have cathepsin A activity, but its substrate specificity, inactivation by heating, and inhibition by p-chloromercuriphenyl sulfonic acid (20, 21) distinguish it from PCP.
PCP activity in cultured fibroblasts remained constant between the third and tenth passages in culture. The enzymic activity in IMR-90 lung fibroblasts was unaffected by either epidermal or fibroblast growth factors, although these polypeptide growth factors stimulated cell replication. In contrast, hydrocortisone influenced both cell growth and PCP activity. Low concentrations ofthe steroid (2 ,uM) decreased PCP activity relative to that in untreated cells, but at higher concentrations (0.2 mM) the enzyme activity was increased. The activity of another enzyme, f8-glucuronidase was affected similarly by hydrocortisone, and at all concentrations of the steroid, the enzyme activities were proportional to the cell-protein concentration. The decreased PCP activity at a low concentration of hydrocortisone may be because of stimulated cell replication (24) , since the enzyme activity is expressed relative to the cell number. The apparent increase in PCP activity in cells treated with higher concentrations ofthe steroid probably reflects an inhibition of DNA synthesis and thus, cell replication (25, 26) .
Fibroblasts cultured both from synovium and synovial fluid from rheumatic joints have PCP activity. The activity in synovial fluid was enhanced by dilution, which suggests that it also contains an inhibitorofPCP.
These experiments show that PCP has a wider distribution than was originally thought. The development of a sensitive and accurate assay for PCP enabled us to examine the enzyme in various tissues and cultured cells. The 
